MAP2K7 and breast carcinoma: Here we find that lung fibroblasts take up MDA-MB-231 breast cancer cell-derived EVs mainly through macropinocytosis and clathrin-independent, caveolae-mediated endocytosis, and that MEK inhibition by Trametinib mainly suppresses macropinocytosis.